- Home
- CRNX vs DAN Comparison
CRNX vs DAN Comparison
Compare CRNX & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- DAN
- Stock Information
- Founded
- CRNX 2008
- DAN 1904
- Country
- CRNX United States
- DAN United States
- Employees
- CRNX N/A
- DAN N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- DAN Auto Parts:O.E.M.
- Sector
- CRNX Health Care
- DAN Consumer Discretionary
- Exchange
- CRNX Nasdaq
- DAN Nasdaq
- Market Cap
- CRNX 2.8B
- DAN 2.5B
- IPO Year
- CRNX 2018
- DAN N/A
- Fundamental
- Price
- CRNX $33.77
- DAN $20.87
- Analyst Decision
- CRNX Strong Buy
- DAN Buy
- Analyst Count
- CRNX 7
- DAN 5
- Target Price
- CRNX $74.33
- DAN $23.20
- AVG Volume (30 Days)
- CRNX 1.1M
- DAN 1.5M
- Earning Date
- CRNX 11-11-2025
- DAN 10-29-2025
- Dividend Yield
- CRNX N/A
- DAN 1.91%
- EPS Growth
- CRNX N/A
- DAN N/A
- EPS
- CRNX N/A
- DAN N/A
- Revenue
- CRNX $1,392,000.00
- DAN $9,938,000,000.00
- Revenue This Year
- CRNX $489.51
- DAN N/A
- Revenue Next Year
- CRNX $661.93
- DAN N/A
- P/E Ratio
- CRNX N/A
- DAN N/A
- Revenue Growth
- CRNX 0.51
- DAN 7.73
- 52 Week Low
- CRNX $24.10
- DAN $7.58
- 52 Week High
- CRNX $62.53
- DAN $21.40
- Technical
- Relative Strength Index (RSI)
- CRNX 56.44
- DAN 67.63
- Support Level
- CRNX $33.19
- DAN $20.23
- Resistance Level
- CRNX $37.23
- DAN $21.40
- Average True Range (ATR)
- CRNX 1.45
- DAN 0.48
- MACD
- CRNX 0.11
- DAN -0.03
- Stochastic Oscillator
- CRNX 52.12
- DAN 69.36
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About DAN Dana Incorporated
Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.